FBXL5 and cervical carcinoma: The inhibitor of ankyrin repeats, SH3 domains, and proline-rich regions protein (iASPP), a key inducer of epithelial-mesenchymal transition (EMT), promotes cisplatin resistance by targeting FBXL5 and BTG3 through miR-20a in cervical cancer (110).